CIT Group Inc. (CIT) is Trading Lower on Unusual Volume for December 21

Equities Staff |

CIT Group Inc. (CIT) experienced unusually high volume on Dec. 21, as the stock lost 0.59% to a closing price of $40.26. The stock saw 5.86 million shares trade hands over the course of the day on 21,316 trades. Given that the stock’s average daily volume over the last month has been 1.7 million shares a day, this represents a pretty substantial spike over the norm.

CIT Group Inc. has a P/B ratio of 0.75. It also has a P/E ratio of 6.5. The stock has traded between $49.27 and $39.18 over the last 52-weeks, its 50-day SMA is now $42.24, and its 200-day SMA $44.40.

CIT Group Inc provides financing, leasing and advisory services principally to middle market companies in industries primarily in North America, and equipment financing and leasing solutions to the transportation industry worldwide.

Headquartered in New York, NY, CIT Group Inc. has 4,960 employees and is currently under the leadership of CEO Ellen R. Alemany / John A. Thain.

For a complete fundamental analysis analysis of CIT Group Inc., check out’s Stock Valuation Analysis report for CIT. To see the latest independent stock recommendations from’s analysts, visit our Research section.


The Russell 3000 is not well known outside the world of finance, but it’s one of the strongest indices out there for getting a broad sense of the stock market. Unlike the better-known Dow Jones Industrial Average or S&P 500, membership on the Russell 3000 isn’t selected by committee. It’s simply the 3,000 most valuable companies in the country.

With 3,000 stocks making up the index, it gives a broad look at the markets, including the small-and mid-cap companies that aren’t on the Dow or the S&P 500. And with a rules-based system for determining membership, there’s no bias that could potentially limit membership. That’s why many financial professionals will turn to the Russell 3000 long before the better-known indices when trying to take the temperature of the market.

For more news on the financial markets, go to Also, learn more about our independent proprietary equity research reports and our robust do-it-yourself Stock Valuation Analysis reports in our Research section.

All data provided by QuoteMedia and was accurate as of 4:30PM ET.

DISCLOSURE: The views and opinions expressed in this article are those of the authors, and do not represent the views of Readers should not consider statements made by the author as formal recommendations and should consult their financial advisor before making any investment decisions. To read our full disclosure, please go to:


Emerging Growth

Beleave Inc.

Beleave Inc is a biotech company. The Company is engaged in the production of medical marijuana under the Marihuana for Medical Purposes Regulations outlined by Health Canada.

Private Markets

The Green Organic Dutchman

The Green Organic Dutchman Ltd. ("TGOD") produces farm grown, organic cannabis for medical use. The company grows its high quality organic cannabis in small batches using craft growing, all natural…

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.